Newsroom
Sorted by: Latest
-
GE HEALTHCARE TECHNOLOGIES INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On April 29, 2026, GE HealthCare reported its financial results for the first quar...
-
ERASCA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ:ERAS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On April 28, 2026, Erasca disclosed receipt of a letter from Revolution Medicines alleging that Erasca’s ERA...
-
QIAGEN N.V. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Qiagen N.V. (“Qiagen” or the “Company”) (NYSE:QGEN). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 5, 2026, Qiagen released fourth quarter 2025 earnings and stated that QuantiFERON would accelerate...
-
THE MARZETTI COMPANY INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against The Marzetti Company (“Marzetti” or the “Company”) (NASDAQ:MZTI). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On May 4, 2026, Marzetti reported its third quarter fiscal 2026 financial results. Among other thi...
-
AEVEX Corp Announces First Quarter 2026 Earnings Release, Conference Call, and Webcast
SOLANA BEACH, Calif.--(BUSINESS WIRE)--AEVEX Corp. (NYSE: AVEX), today announced it will issue financial results for the Company's first quarter fiscal year 2026 after financial markets close on Wednesday, May 20, 2026. Management will host a conference call and live audio webcast to discuss the results at 5:00 p.m. Eastern Daylight Time. Hosting the call and webcast to review results for the first quarter fiscal year 2026 will be Chief Executive Officer, Roger Wells; Chief Financial Officer, T...
-
POET INVESTOR REMINDER: POET Technologies Inc. Investors Have Until June 29, 2026 To Seek Lead Plaintiff Role – Contact Kirby McInerney LLP
NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your POET Technologies Inc. (“POET” or the “Company”) (NASDAQ:POET) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until June 29, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline...
-
OPTION CARE HEALTH, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ:OPCH). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 24, 2026, Option Care Health announced fourth quarter 2025 earnings. On...
-
CALIX, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Calix, Inc. (“Calix” or the “Company”) (NYSE:CALX). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On April 21, 2026, Calix reported results for the first quarter of 2026 earnings, including that “Non-GAAP gross...
-
Samenvatting: Venture Global kondigt LNG-koopovereenkomsten aan met TotalEnergies en Vitol
ARLINGTON, Va.--(BUSINESS WIRE)--Vandaag heeft Venture Global, Inc. (NYSE: VG) de ondertekening van twee bindende overeenkomsten met TotalEnergies en Vitol aangekondigd voor de aankoop van extra vloeibaar aardgas (LNG) uit de VS van Venture Global. Venture Global heeft een nieuwe, bindende overeenkomst met TotalEnergies aangekondigd voor de aankoop van circa 0,85 miljoen ton LNG per jaar van Venture Global gedurende ongeveer vijf jaar, ingaande in 2026. Daarnaast zijn Venture Global en Vitol ov...
-
Fortive Announces Pricing of Offering of Senior Notes
EVERETT, Wash.--(BUSINESS WIRE)--Fortive Corporation (“Fortive”) (NYSE: FTV) today announced that it has priced its registered offering (the “offering”) of $600 million aggregate principal amount of its 4.750% Notes due 2031 (the “2031 notes”) and $500 million aggregate principal amount of its 5.250% Notes due 2036 (the “2036 notes” and, together with the 2031 notes, the “notes”). The 2031 notes will bear interest at 4.750% per annum and mature on May 15, 2031, and the 2036 notes will bear inte...